Transcription

1 215 Research

2

3 UNITED NATIONS OFFICE ON DRUGS AND CRIME Vienna World Drug Report 215 UNITED NATIONS New York, 215

4 United Nations, May 215. All rights reserved worldwide. ISBN: eisbn: United Nations publication, Sales No. E.15.XI.6 This publication may be reproduced in whole or in part and in any form for educational or non-profit purposes without special permission from the copyright holder, provided acknowledgement of the source is made. The United Nations Office on Drugs and Crime (UNODC) would appreciate receiving a copy of any publication that uses this publication as a source. Suggested citation: United Nations Office on Drugs and Crime, World Drug Report 215 (United Nations publication, Sales No. E.15.XI.6). No use of this publication may be made for resale or any other commercial purpose whatsoever without prior permission in writing from UNODC. Applications for such permission, with a statement of purpose and intent of the reproduction, should be addressed to the Research and Trend Analysis Branch of UNODC. DISCLAIMER The content of this publication does not necessarily reflect the views or policies of UNODC or contributory organizations, nor does it imply any endorsement. The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of UNODC concerning the legal status of any country, territory or city or its authorities, or concerning the delimitation of its frontiers or boundaries. Comments on the report are welcome and can be sent to: Division for Policy Analysis and Public Affairs United Nations Office on Drugs and Crime P.O. Box 5 14 Vienna Austria Tel.: (+43) Fax: (+43) Website:

5 PREFACE UNODC is pleased to present the findings of the World Drug Report 215, based on the best available data and our longstanding research expertise in the many complex facets of drugs and crime. Member States are engaged in intensive discussions on the way forward to address the world drug problem, with the General Assembly special session on this topic to take place next year. This report is aimed at providing needed research input and informing collective responses to the challenges posed by the production, trafficking and use of illicit drugs. The continuing discussions leading to the special session of the General Assembly have recognized the need for drug control policies that are balanced, comprehensive and integrated, with a focus on health and carried out with respect for human rights. Numerous Security Council and General Assembly resolutions have emphasized the fact that the harm caused by illicit drugs has a significant impact on peace, security and development. The ongoing debate on the post-215 development agenda has further underscored the importance of promoting justice and the rule of law, and of addressing the threats that undermine them, including drugs, violence and organized crime. Risk factors and circumstances that can render people more vulnerable to illicit drugs, as well as facilitate the establishment and expansion of illegal markets, are often related to issues of development, rule of law and governance. Policies can never be pursued in isolation, and drug control is no exception. The need for such integrated responses, encompassing robust criminal justice action to disrupt organized criminal networks, measures to ensure access to controlled medications for medical purposes, and evidence- and health-based approaches to prevention and treatment, is more evident than ever. The vulnerability of Africa to drugs and crime remains a grave concern, with increasing seizures of heroin indicating the region s role as a key transit area for global drug trafficking routes. These illicit flows bring with them other forms of organized crime, and undermine security, health and development in an already-fragile region. The nexus between organized crime and terrorism in which illicit drug trafficking appears to play a role poses a serious threat, as emphasized by recent Security Council resolutions calling for redoubled efforts to prevent terrorists from benefiting from transnational organized crime. Record opium poppy cultivation in Afghanistan continues to present formidable challenges for the country and the international community. Global opium poppy cultivation in 214 reached its highest level since the late 193s. The increase in estimated opium and heroin production has not yet been reflected in an increase in heroin supply in most regions. But in some countries there have been signs of increases in heroin-related indicators such as mortality and health emergencies, and in others indications of increased purity and lower prices. An unacceptable number of drug users worldwide continue to lose their lives prematurely, with an estimated 187,1 drug-related deaths in 213. Only one out of six problem drug users globally has access to treatment. Women in particular appear to face barriers to treatment while one out of three drug users globally is a woman, only one out of five drug users in treatment is a woman. Clearly more work needs to be done to promote the importance of understanding and addressing drug dependence as a chronic health condition requiring, like HIV/AIDS, longterm, sustained treatment and care. UNODC remains committed to working with Member States, as well as our United Nations and other partners, to further these efforts. The thematic chapter of this year s report focuses on alternative development. Alternative development presents many challenges, with programmes often undertaken in marginalized, isolated areas with limited government control, unclear land rights and lack of infrastructure, where few other development actors may be operating. Nevertheless, the decades-long experience of UNODC has made it clear that alternative development can work, when initiatives are informed by a long-term vision, sustained with adequate funding and political support, and integrated into a broader development and governance agenda. Approached holistically, alternative development has the potential to break the vicious cycle trapping poor farmers and to act as a catalyst for viable livelihoods that do not depend on illicit cultivation. The World Drug Report 215 chapter on alternative development, based on reviews of successful projects, highlights factors that have contributed to fostering a sustainable licit economy, including transfer of skills and access to land, credit and infrastructure, as well as marketing support and access to markets. The chapter further underlines the potential of alternative development to contribute to environmental protection, empower women and support communities affected by other forms of crime, including illegal mining or wildlife and forest crime. Unfortunately, the report also shows that widespread political support for alternative development has not been matched by funding. Member States have repeatedly endorsed alternative development. There is also a welcome trend towards South-South cooperation, with the exchange of best practices and local experiences, as well as increased financial investments and 215 WORLD DRUG REPORT

6 iv technical support from countries such as Bolivia (Plurinational State of), Colombia, Peru and Thailand. Nevertheless, overall gross disbursements of alternative development funds from countries of the Organization for Economic Cooperation and Development accounted for just.1 per cent of global development assistance in 213. The post-215 development agenda and the process towards the special session of the General Assembly on the world drug problem to be held in 216 can provide an important impetus for alternative development efforts, as well as for broader interventions addressing supply and demand. Impoverished farmers growing coca and opium poppy to eke out an unsustainable living; fragile regions and communities reeling from the harm caused by the transit of illicit drugs, on their way to richer markets; women, men and children struggling with drug dependence, with nowhere to turn. Illicit drugs hurt so many people, in so many places, and they need our help. The international community must respond with determination and compassion, and I hope the World Drug Report 215 will help to reinforce this message. I would like to take this opportunity to thank Member States for their help in producing this report, which relies on the willingness to share data, promote transparency and provide assistance. That is to say, it relies on the very spirit of openness and shared responsibility needed to address the multidimensional challenges posed by illicit drugs, and we count on your continued support. Yury Fedotov Executive Director United Nations Office on Drugs and Crime

8 Acknowledgements The World Drug Report 215 was prepared by the Research and Trend Analysis Branch, Division for Policy Analysis and Public Affairs, United Nations Office on Drugs and Crime, under the supervision of Jean-Luc Lemahieu, Director of the Division for Policy Analysis and Public Affairs, and Angela Me, Chief of the Research and Trend Analysis Branch. Core team Research, study preparation and drafting Hamid Azizi Sabrina Levissianos Anneke Bühler João Matias Coen Bussink Kamran Niaz Giovanna Campello Philip Davis Chloé Carpentier Thomas Pietschmann Natascha Eichinger Martin Raithelhuber Fabienne Hariga Ehab Salah Jorrit Kamminga Saurabh Sati Anja Korenblik Janie Shelton Igor Koutsenok Justice Tettey Riku Lehtovuori Juanita Vasquez Graphic design and layout Suzanne Kunnen Kristina Kuttnig Data processing and mapping support Gerald Kandulu Preethi Perera Umidjon Rahmonberdiev Ali Saadeddin Editing Jonathan Gibbons Coordination Francesca Massanello Review and comments The report also benefited from the expertise and valuable contributions of several colleagues in the Division for Operations and the Division for Treaty Affairs. The Research and Trend Analysis Branch is also grateful for the contributions, advice and research conducted by the Scientific Advisory Committee, which was formed specifically to provide scientific advice on the research to be undertaken for chapter 2 of the present report. Members of the Committee were: Daniel Brombacher Jeremy Milsom Doris Buddenburg Ramrada Ninnad Rodrigo Daza Jorge Rios M.L. Dispanadda Diskul Alejandro Vassilaqui Mimoun El Maghraoui Fernando Villaran Guillermo García Miranda Jochen Wiese Tom Kramer The Research and Trend Analysis Branch is also grateful for the contributions to chapter 2 of the present report by the United Nations Office on Drugs and Crime country offices in Afghanistan, Bolivia (Plurinational State of), Colombia, Myanmar and Peru, as well as the Regional Office for South-East Asia and the Pacific. The research for chapter 2 of the present report was made possible by the generous contribution of the Russian Federation.

9 EXPLANATORY NOTES The boundaries and names shown and the designations used on maps do not imply official endorsement or acceptance by the United Nations. A dotted line represents approximately the line of control in Jammu and Kashmir agreed upon by India and Pakistan. The final status of Jammu and Kashmir has not yet been agreed upon by the parties. Disputed boundaries (China/India) are represented by cross-hatch owing to the difficulty of showing sufficient detail. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities or concerning the delimitation of its frontiers or boundaries. Countries and areas are referred to by the names that were in official use at the time the relevant data were collected. All references to Kosovo in the present publication should be understood to be in compliance with Security Council resolution 1244 (1999). Since there is some scientific and legal ambiguity about the distinctions between drug use, drug misuse and drug abuse, the neutral terms drug use and drug consumption are used in the present report. All analysis contained in this report is based on the official data submitted by member States to the United Nations Office on Drugs and Crime through the annual report questionnaire unless indicated otherwise. The data on population used in the present report are from: United Nations, Department of Economic and Social Affairs, Population Division, World Population Prospects: The 212 Revision. References to dollars ($) are to United States dollars, unless otherwise stated. References to tons are to metric tons, unless otherwise stated. The following abbreviations have been used in the present report: ADHD attention deficit hyperactivity disorder ATS amphetamine-type stimulants CBD cannabidiol CICAD Inter-American Drug Abuse Control Commission (Organization of American States) DEA Drug Enforcement Administration EMCDDA European Monitoring Centre for Drugs and Drug Addiction Europol European Police Office FAO Food and Agriculture Organization of the United Nations FWID females who inject drugs GDP gross domestic product GIZ German Agency for International Cooperation INCB International Narcotics Control Board INCSR International Narcotics Control Strategy Report, of the United States State Department LSD lysergic acid diethylamide MDA 3,4-methylenedioxyamphetamine MDMA 3,4-methylenedioxymethamphetamine MWID 3,4-MDP-2-P 4-MEC NPS males who inject drugs 3,4-methylenedioxyphenyl-2- propanone mythylethcathinone new psychoactive substances OECD Organization for Economic Cooperation and Development PWID people who inject drugs SAMHSA THC Substance Abuse and Mental Health Service Administration (United States) 9 -tetrahydrocannabinol UNAIDS Joint United Nations Programme on HIV/AIDS USAID United States Agency for International Development UNFDAC United Nations Fund for Drug Abuse Control UNDCP United Nations International Drug Control Programme UNODC United Nations Office on Drugs and Crime WHO World Health Organization WTO World Trade Organization 215 WORLD DRUG REPORT

10

11 EXECUTIVE SUMMARY The World Drug Report presents a comprehensive annual overview of the latest developments in the world s illicit drug markets by focusing on the production of, trafficking in and consumption of the main illicit drug types and their related health consequences. Chapter 1 of the World Drug Report 215 provides a global overview of the supply of and demand for opiates, cocaine, cannabis, amphetamine-type stimulants (ATS) and new psychoactive substances (NPS), as well as their impact on health, and reviews the scientific evidence on approaches to drug use prevention and addresses general principles for effective responses to treatment for drug use. Chapter 2 focuses on how alternative development, within the broader context of the development agenda, aims to break the vicious cycle of illicit crop cultivation by providing farmers with alternative livelihoods. According to the most recent data available, there has been little change in the overall global situation regarding the production, use and health consequences of illicit drugs. The health consequences of illicit drug use continue to be a matter of global concern, as the vast majority of problem drug users continue to have no access to treatment. Furthermore, the increase in global opium poppy cultivation and opium production to record levels has yet to have major repercussions on the global market for opiates. This raises concerns about the size of the challenge to law enforcement posed by increasingly sophisticated and versatile organized criminal groups. Drug use and its health consequences It is estimated that a total of 246 million people, or 1 out of 2 people between the ages of 15 and 64 years, used an Global trends in the estimated number of drug users, Drug users (millions) Number of illicit drug users Number of problem drug users Source: UNODC, responses to annual report questionnaire. Note: Estimated percentage of adults (aged 15-64) who have used drugs in the past year. illicit drug in 213. That represents an increase of 3 million over the previous year but, because of the increase in the global population, illicit drug use has in fact remained stable. The magnitude of the world drug problem becomes more apparent when considering that more than 1 out of 1 drug users is a problem drug user, suffering from drug use disorders or drug dependence. In other words, some 27 million people, or almost the entire population of a country the size of Malaysia, are problem drug users. Almost half (12.19 million) of those problem drug users inject drugs, and an estimated 1.65 million of those who inject drugs were living with HIV in 213. This places a heavy burden on public health systems in terms of the prevention, treatment and care of drug use disorders and their health consequences. Only one out of every six problem drug users in the world has access to treatment, as many countries have a large shortfall in the provision of services. The annual number of drug-related deaths (estimated at 187,1 in 213) has remained relatively unchanged. An unacceptable number of drug users continue to lose their lives prematurely, often as a result of overdose, even though overdose-related deaths are preventable. Notwithstanding national and regional variations in trends in drug use, the limited data available indicate that the use of opiates (heroin and opium) has remained stable at the global level. Mainly as a result of trends in the Americas and Europe, cocaine use has declined overall, while the use of cannabis and the non-medical use of pharmaceutical opioids have continued to rise. Trends in ATS use vary Global trends in the estimated prevalence of drug use, aged (percentage) Prevalence of problem drug use (percentage) Prevalence of illicit drug use (percentage) Source: UNODC, responses to annual report questionnaire. Note: Estimates are for adults (aged 15-64), based on past-year use. 215 WORLD DRUG REPORT

12 x Global trends in the prevalence of use of various drugs, Prevalence of use (index base = 1 in 29) Amphetamines Cannabis Cocaine "Ecstasy"-group Opiates Opioids Source: UNODC, responses to annual report questionnaire. Note: Based on the estimated percentage of adults (aged 15-64) who have used the substance in the past year. from region to region, and some subregions such as South- East Asia have reported an increase in methamphetamine use. There are also indications that the number of people requiring treatment for cannabis use is increasing in most regions. The evidence suggests that more drug users are suffering from cannabis use disorders, and there is growing evidence that cannabis may be becoming more harmful. This is reflected in the high proportion of persons entering treatment for the first time for cannabis use disorders in Europe, North America and Oceania. According to the limited information available, cannabis ranks first among the drug types for which people in Africa enter treatment for drug use. Cannabis is by far the most frequently used drug in prisons. Though data on the subject are limited, there are indications that one third of prisoners have used a drug at least once while incarcerated. Lifetime and recent (pastmonth) use of heroin in prisons is much higher than that of cocaine, amphetamines or ecstasy. Prison is a highrisk, controlled environment where drug use, including injecting drug use, often takes place in particularly unsafe conditions. This may explain why the prison environment can be characterized by high levels of infectious diseases, particularly HIV but also hepatitis C and tuberculosis, and by limited access to prevention and treatment, which increases the risk of contracting blood-borne viruses. The number of people requiring treatment for ATS use is also increasing globally. This is probably attributable to the sheer weight of numbers, as the prevalence of ATS use is relatively high in Asia, where there is high demand for treatment but the expertise in treating ATS use disorders is not at the same level of sophistication as the expertise in treating opiate use disorders. NPS are marketed as alternatives to internationally controlled drugs and are purported to produce effects similar to those of their traditional counterparts. They have the potential to pose serious risks to public health and safety. Information and research on the potential harm caused by NPS are limited, but the proliferation of the estimated 5 NPS, including mephedrone, poses a health threat to drug users and has increased demand for treatment for drug use. Lifetime, annual and past-month prevalence of drug use in prisons (based on 62 studies from 43 countries over the period 2-213) Prevalence of drug use in prison (percentage) Annual Annual Annual Sources: UNODC, responses to annual report questionnaire; and C. Carpentier, L. Royuela and L. Montanari, The global epidemiology of drug use in prison (215). Note: Symbols represent median prevalence with vertical lines depicting inter-quartile range. Data on lifetime, annual and past-month use are not consistent across studies (this explains why the annual prevalence of cocaine use has a median value lower than the past-month use). Any illicit drug use Cannabis Her in C caine A p eta ines Ecstasy Annual Annual Annual

13 EXECUTIVE SUMMARY xi Even though one out of three drug users is a woman, only one out of five drug users in treatment is a woman. Cocaine remains the primary drug of concern in Latin America and the Caribbean, whereas the use of opiates remains the most problematic form of drug use globally. This can be attributed to the relationship between the use of opiates and injecting drug use, HIV, AIDS and overdose deaths and to the fact that the use of opiates accounts for the majority of treatment admissions for drug use in Asia and Europe. Public perceptions about the rehabilitation of drugdependent persons tend to oversimplify the magnitude of drug dependence. There is no quick and simple remedy for drug dependence. It is a chronic health condition and, as with other chronic conditions, the affected persons remain vulnerable for a lifetime and require long-term and continued treatment. There is a growing body of research showing that many interventions aimed at preventing the initiation of drug use (or the potential transition to drug use disorders) can be effective if they address the different personal and environmental vulnerabilities of children and young people factors that are largely beyond a person s control. A number of social and structural barriers clearly continue to hinder the access of women to treatment for drug use: globally, only one out of five drug users in treatment is a woman even though one out of three drug users is a woman. A large body of evidence has shown that social and biological factors relating to initiation of substance use, continued substance use and the development of problems related to substance use vary considerably between men and women. Men are three times more likely Prevalence of HIV among people who inject drugs, 213 or latest year available Ç ÇÇ ÇÇ Ç Ç ÇÇ Ç ÇÇ Ç Ç % of PWID living with HIV No data provided Note: The boundaries shown on this map do not imply official endorsement or acceptance by the United Nations. Dashed lines represent undetermined boundaries. The dotted line represents approximately the Line of Control in Jammu and Kashmir agreed upon by India and Pakistan. The final status of Jammu and Kashmir has not yet been agreed upon by the parties. The final boundary between the Sudan and South Sudan has not yet been determined. A dispute exists between the Governments of Argentina and the United Kingdom of Great Britain and Northern Ireland concerning sovereignty over the Falkland Islands (Malvinas). 215 WORLD DRUG REPORT

14 xii than women to use cannabis, cocaine and amphetamines, whereas women are more likely than men to misuse prescription opioids and tranquillizers. As the likelihood that initiation of the misuse of tranquillizers and prescription opioids may lead to regular or current use is relatively high compared with other drugs, this remains an area of particular concern for women. Available data on HIV prevalence among people who inject drugs show that, in many countries, women who inject drugs are more vulnerable to HIV infection than their male counterparts and that the prevalence of HIV is higher among women who inject drugs than among their male counterparts. Some progress has been made towards achieving the target set in the 211 Political Declaration on HIV and AIDS of reducing by 5 per cent HIV transmission among people who inject drugs by Although the number of newly diagnosed cases of HIV among people who inject drugs declined by roughly 1 per cent, from an estimated 11, in 21 to 98, in 213, this target is unlikely to be met. The transmission of infectious diseases such as HIV and hepatitis C and the occurrence of drug overdoses are only some of the risk factors that lead to the level of mortality among people who inject drugs being nearly 15 times higher than would normally be expected among people of comparable age and gender in the general population. Not all drug overdoses are fatal; different studies have estimated that only 1 out of 2-25 overdose cases is fatal. Non-fatal overdoses are underreported and are a common experience among drug users; however, the cumulative risk of death increases with each successive overdose. DRUG SUPPLY AND MARKETS The production of cannabis resin continues to be confined to a few countries in North Africa, the Middle East and South-West Asia, whereas cannabis herb is produced in most of the countries in the world. South America continues to account for practically all global cultivation of coca bush, and South-West Asia (Afghanistan) and South- East Asia (mainly the Lao People s Democratic Republic and Myanmar) continue to account for the vast majority of illicit opium poppy cultivation. Although the manufacture of ATS is difficult to assess, there are reports of ATS manufacture in all regions worldwide. There may have been no major change in the regions in which illicit crop cultivation and drug manufacture take place, but the illicit drug markets and the routes along which drugs are smuggled continue to be in a state of flux. The dark net, the anonymous online marketplace used for the illegal sale of a wide range of products, including drugs, is a prime example of the constantly changing situation, and it has profound implications for both law enforcement and drug trafficking. A more classic example of this dynamic aspect is the continued shift in the routes used for smuggling opiates and 46 % 8 % 46 % Share of total numbers of individual seizures 59 % 6 % 35 % kg Share of total quan es seized 1 Political Declaration on HIV and AIDS: Intensifying Our Efforts to Eliminate HIV and AIDS (General Assembly resolution 65/277, annex).

15 EXECUTIVE SUMMARY xiii the fact that Afghan heroin may be reaching new markets. The growing importance of Africa as a transit area for Afghan heroin bound for Europe and other regions has been reflected in increasing seizures of heroin reported in recent years in some African countries, particularly in East Africa. Recent seizures also suggest that it may have become more common for large shipments of Afghan heroin to be smuggled across the Indian Ocean into East and Southern Africa. Moreover, Africa continues to be used as a trans-shipment area for smuggling cocaine across the Atlantic into Europe, and Eastern Europe is emerging as a transit area and as a destination. The quantities being smuggled are small but this may be an indication that the cocaine market is moving eastwards. West Africa appears to have become an established source of the methamphetamine smuggled into East and South- East Asia via Southern Africa or Europe, with new trafficking routes linking previously unconnected regional methamphetamine markets. The established market for methamphetamine in East and South-East Asia continues to grow, while there are also indications of increasing methamphetamine use in parts of North America and Europe. As opiates originating in Myanmar may be unable to meet the demand in South-East Asia, the so-called southern route could be increasing in importance as a conduit for smuggling Afghan heroin southwards from Afghanistan through Pakistan or the Islamic Republic of Iran. Trafficking networks using the Balkan route to smuggle Afghan heroin into Europe may be experimenting with a new route, leading through the Caucasus, and there are indications of heroin being trafficked from Iraq rather than from the Islamic Republic of Iran. Not only are drug trafficking routes undergoing change, but there is also evidence that organized criminal groups, which in the past may have limited their trafficking activities to one drug type, are diversifying. For example, groups that previously focused on heroin trafficking appear to be increasingly engaging in trafficking in cannabis resin and methamphetamine. To a certain extent, there has also been a shift in the focus of the trafficking routes themselves. There is increasing evidence that routes traditionally used for smuggling one type of drug are now being used for smuggling other drug types. While there appears to be an evolution in the countries reported to be used as transit hubs for certain drugs, such as African countries being used as transit areas for heroin and cocaine, certain African countries are also increasingly being used as transit areas for different types of drugs. Opiates According to the limited information available, global prevalence of the use of opioids (.7 per cent of the world s adult population, or 32.4 million users) and the use of Global potential opium production, Production (tons) 9, 8, 7, 6, 5, 4, 3, 2, 1, Rest of the World Mexico Myanmar Lao People's Democratic Republic Afghanistan Source: Period : UNODC; since 23: national illicit crop monitoring system supported by UNODC. opiates (.4 per cent, or 16.5 million users worldwide) has remained stable, whereas global opium poppy cultivation in 214 reached the highest level since the late 193s. This was mainly attributable to the fact that opium poppy cultivation reached historically high levels in the main country in which opium poppy is cultivated, Afghanistan, where potential production of opium also continued to increase. Global opium production reached 7,554 tons in 214, also the second highest level since the late 193s, though global seizures of opium, heroin and illicit morphine decreased by 6.4 per cent from 212 to 213. The increase in estimated opium and heroin production has not yet been reflected in an increase in heroin supply in most regions. The destination of the additional quantities of heroin is unclear, but there are signs of increases in the availability of heroin and in heroin-related indicators such as mortality and medical emergencies in some countries. The prevalence of opioid use remains high in North America (3.8 per cent) in relation to the global average. In the United States of America, there are indications of a partial shift in the use of opioids towards heroin use, attributable in part to changes in the formulation of OxyContin, one of the main prescription opioids that are misused, as well as an increase in the availability of heroin and a decrease in its price in some parts of the country. With the number of heroin-related deaths increasing considerably (from 5,925 in 212 to 8,257 in 213), reaching the highest level in a decade, the number of drug-related deaths continues to rise in the United States. There are signs of change in the supply of heroin in different regions. In North America, although 9 per cent of 215 WORLD DRUG REPORT

16 xiv Main global trafficking flows of opiates Canada WESTERN AND CENTRAL EUROPE EASTERN EUROPE Russian Federation Pakistan United States of America SOUTH- EASTERN EUROPE Turkey Islamic Republic of Iran CENTRAL ASIA Afghanistan Pakistan China Canada Mexico Persian Gulf area & Middle East SOUTHERN ASIA Myanmar WEST AFRICA Colombia Ethiopia Kenya Malaysia SOUTH-EAST ASIA Flows of heroin from/to countries or regions Opiate trafficking generated by production in Latin America Opiate trafficking generated by production in Myanmar/Lao People s Democratic Republic SOUTH AMERICA United Republic of Tanzania Mozambique OCEANIA Opiate trafficking generated by production in Afghanistan South Africa Balkan route Northern route Southern route 1, 2, km The designations employed and the presentation of material on this map do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted line represents approximately the Line of Control in Jammu and Kashmir agreed upon by India and Pakistan. The final status of Jammu and Kashmir has not yet been agreed upon by the parties. Final boundary between the Republic of Sudan the Republic of South Sudan has not yet been determined. A dispute exists between the Governments of Argentina and the United Kingdom of Great Britain and Northern Ireland concerning sovereignty over the Falkland Islands (Malvinas). * The trafficking routes represented on the above map should be considered broadly indicative and based on data analysis rather than definitive route outlines. Such analyses are based upon on data related to official drug seizures along the trafficking routes as well as official country report and Annual Response Questionnaires. Routes may deviate to other countries along the routes and there are numerous secondary flows that may not be represented. Sources: UNODC annual report questionnaire and individual drug seizure database. UNODC Afghan Opiate Trade Project. Sources: UNODC, responses to annual report questionnaire and individual drug seizure database. Notes: The trafficking routes represented on this map should be considered broadly indicative and based on data analyses rather than definitive route outlines. Such analyses are based on data related to official drug seizures along the trafficking route as well as official country reports and responses to annual report questionnaires. Routes may deviate to other countries that lie along the routes and there are numerous secondary flows that may not be reflected. The boundaries shown on this map do not imply official endorsement or acceptance by the United Nations. Dashed lines represent undetermined boundaries. The dotted line represents approximately the Line of Control in Jammu and Kashmir agreed upon by India and Pakistan. The final status of Jammu and Kashmir has not yet been agreed upon by the parties. The final boundary between the Sudan and South Sudan has not yet been determined. the heroin in Canada originates in Afghanistan, the United States continues to be supplied by heroin manufactured in Central and South America. However, analysis of seizures indicates that while Afghan heroin currently accounts for relatively little of the heroin seized in the United States, this may be changing. In Oceania, there have been fluctuations in the Australian market between the supply of Afghan heroin and heroin originating in the Lao People s Democratic Republic or Myanmar, but it seems that in 213 the latter was predominant. This underlines the fact that the reach of organized criminal networks continues to be global and that organized criminal groups are becoming increasingly sophisticated and versatile. In Europe, the heroin market is also marked by variations, albeit at the subregional level. There are indications of a stable or downward trend in the use of heroin in Western and Central Europe, while heroin seizures have recently increased in Eastern and South-Eastern Europe, where the absence of new data prevents the assessment of recent trends in the prevalence of drug use. In the absence of any recent reliable data on the extent of the use of opioids in most parts of Asia, it is difficult to determine a trend, but the use of opioids is generally considered to be stable. Asia remains the world s largest market for opiates, accounting for an estimated two thirds of all users of opiates, and the total number of registered heroin users in China is increasing. Data on Africa remain limited, but it is likely that the increasing importance of the region as a transit area for Afghan heroin bound for markets in other regions has had an impact on the use of opiates in Africa. Cocaine Not only did coca bush cultivation continue to decline in 213, reaching the lowest level since the mid-198s, when estimates first became available, but the annual prevalence Coca bush cultivation, Hectares 2, 18, 16, 14, 12, 1, 8, 6, 4, 2, Peru Bolivia (Plurinational State of) Colombia Source: UNODC, responses to annual report questionnaire and other official sources.

17 EXECUTIVE SUMMARY xv Main global trafficking flows of cocaine Canada WESTERN AND CENTRAL EUROPE United States of America China Canada United States of America Colombia Peru Chile Argentina Qatar Australia China Singapore Mexico CENTRAL AMERICA CARIBBEAN Ecuador Venezuela (Bol. Rep. of) Colombia Cabo Verde WEST AFRICA Oman India Singapore Hong Kong, China Brazil Hong Kong, China Australia Flows of cocaine from/to countries or regions Main trafficking Other trafficking Most frequently mentioned countries of provenance for individual drug seizure cases Peru Brazil Bolivia (Plur. State of) Paraguay Chile Argentina South Africa Australia 1, 2, km Note: The designations employed and the presentation of material on this map do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted line represents approximately the Line of Control in Jammu and Kashmir agreed upon by India and Pakistan. The final status of Jammu and Kashmir has not yet been agreed upon by the parties. Final boundary between the Republic of Sudan the Republic of South Sudan has not yet been determined. A dispute exists between the Governments of Argentina and the United Kingdom of Great Britain and Northern Ireland concerning sovereignty over the Falkland Islands (Malvinas). * The trafficking routes represented on the above map should be considered broadly indicative and based on data analysis rather than definitive route outlines. Such analyses are based upon on data related to official drug seizures along the trafficking routes as well as official country report and Annual Response Questionnaires. Routes may deviate to other countries along the routes and there are numerous secondary flows that may not be represented. Sources: UNODC annual report questionnaire and individual drug seizure database. Source: UNODC, responses to annual report questionnaire and individual drug seizure database. Notes: The trafficking routes represented on this map should be considered broadly indicative and based on data analyses rather than definitive route outlines. Such analyses are based on data related to official drug seizures along the trafficking routes as well as official country reports and responses to annual report questionnaires. Routes may deviate to other countries that lie along the routes and there are numerous secondary flows that may not be reflected. The boundaries shown on this map do not imply official endorsement or acceptance by the United Nations. Dashed lines represent undetermined boundaries. The dotted line represents approximately the Line of Control in Jammu and Kashmir agreed upon by India and Pakistan. The final status of Jammu and Kashmir has not yet been agreed upon by the parties. The final boundary between the Sudan and South Sudan has not yet been determined. of cocaine use (.4 per cent of the adult population) also continued to decline in Western and Central Europe and North America. In those subregions, which, along with South America, have the world s largest cocaine markets, the prevalence of cocaine use is highest. Supply reduction measures may have contributed to the decline in coca bush cultivation in the coca-producing countries, leading to a reduction in the availability of cocaine and the shrinking of some of the principal cocaine markets. In addition to the human cost of cocaine manufacture and trafficking, illicit coca bush cultivation and the transformation of coca into cocaine continue to cause serious environmental damage even though coca bush cultivation has decreased. In Colombia alone, roughly 29, hectares of forest were lost as a direct result of coca crop cultivation between 21 and 213, while the slash-and-burn method used to clear new plots has led to increased erosion. Further environmental damage has been caused by the herbicides and fertilizers used in coca bush cultivation and the chemicals employed in the transformation of coca into cocaine. Cannabis Cannabis use is increasing and continues to be high in West and Central Africa, Western and Central Europe and Oceania, as well as in North America, where the most recent data available indicate an increase in the prevalence of cannabis use in the United States. Europe is still one of the world s largest markets for cannabis resin, but its use is concentrated in a few countries. The use of cannabis herb is more evenly spread across European countries, and the market in Western and Central Europe is shifting from cannabis resin to cannabis herb. Advances in cannabis plant cultivation techniques and the use of genetically selected strains have led to an increase in the number of cannabis harvests, as well as in the yield and potency of cannabis. The potency of cannabis, commonly measured in terms of the concentration of THC (Δ 9 -tetrahydrocannabinol, the main psychoactive ingredient in cannabis), has been increasing in many markets over the past decade, leading to growing concern about the potential of cannabis to cause serious health problems. Despite the fact that increasing professionalism and sophistication have enhanced the capacity of cannabis plant growers to avoid detection by law enforcement authorities, data for 213 show an increase in the quantities of cannabis herb and cannabis resin seized worldwide. Synthetic drugs: amphetamine-type stimulants and new psychoactive substances The global market for synthetic drugs continues to be dominated by methamphetamine. The increasingly diversified market for methamphetamine is expanding in East and South-East Asia, where it accounts for a large share 215 WORLD DRUG REPORT

18 xvi Methamphetamine flows as perceived by recipient countries, Eastern Europe East Asia North America Western and Central Europe South- Eastern Europe Western Asia Central Asia East Asia Middle East Central America West Africa East Africa South-East Asia South America Oceania Southern Africa Oceania Methamphetamine flows 1, 2, km Source: UNODC, responses to annual report questionnaire, Note: The origins of the flow arrows do not necessarily indicate the source/manufacture of methamphetamine. These arrows represent the flows as perceived by recipient countries. Flow arrows represent the direction of methamphetamine trafficking and are not an indication of the quantity trafficked. The boundaries shown on this map do not imply official endorsement or acceptance by the United Nations. Dashed lines represent undetermined boundaries. The dotted line represents approximately the Line of Control in Jammu and Kashmir agreed upon by India and Pakistan. The final status of Jammu and Kashmir has not yet been agreed upon by the parties. The final boundary between the Sudan and South Sudan has not yet been determined. of the people receiving treatment for drug use in a number of countries, and use of crystalline methamphetamine is increasing in parts of North America and Europe. Surging seizures since 29 also point to a rapid expansion in the global ATS market, with the total quantity of seized ATS almost doubling to reach over 144 tons in 211 and 212, the highest level since the United Nations Office on Drugs and Crime (UNODC) began systematic monitoring, and remaining at a comparatively high level in 213. According to seizure data, the global ecstasy market is smaller than the global market for amphetamine and methamphetamine and remains confined to a few regions. East and South-East Asia and Oceania may be emerging as a driver of the global market for ecstasy, while the market seems to be on the decline in the Americas, where ecstasy seizures dropped by 81 per cent between 29 and 212. The largest ecstasy markets continue to be East and South-East Asia and Oceania, although seizures of ecstasy declined there in 213. The ecstasy market has been on the decline in several European countries for some time, with mephedrone and other NPS perhaps serving as a substitute. The use of mephedrone and synthetic cannabinoids may have declined in some markets in recent years, but a growing number of countries have reported a wider range of emerging NPS, as well as worrying developments such as the injecting use of NPS. There continue to be limited data on recent developments in injecting drug use and polydrug use involving NPS; these particular forms of drug use Number of new psychoactive substances reported, Source: UNODC, early warning advisory on NPS, Note: This graph represents only the number of different NPS reported during the respective reporting year. Not all NPS reported in one year were necessarily reported in the following year(s) Number of new psychoactive substances reported in current year for the first time Number of new psychoactive substances reported in current year but not for the first time

19 EXECUTIVE SUMMARY xvii could pose a serious challenge for providers of treatment for drug use and health-care providers. The sheer number, diversity and transient nature of NPS currently on the market partly explain why there are still only limited data available on the prevalence of use of many NPS. Those difficulties also explain why both the regulation of NPS and the capacity to address health problems related to NPS continue to be challenging. Different countries report that NPS continue to proliferate in the marketplace, in terms of both quantity and diversity. By December 214, a total of 541 NPS had been reported by 95 countries and territories to the UNODC early warning advisory. Synthetic cannabinoids continued to account for the majority of NPS reported in 214 (39 per cent); they were followed by phenethylamines (18 per cent) and synthetic cathinones (15 per cent). The growing number of NPS available worldwide indicates that the market for synthetic drugs is becoming even more diversified. ALTERNATIVE DEVELOPMENT Illicit crop cultivation: breaking the vicious cycle Illicit crop cultivation is driven by situation-specific combinations of vulnerability and opportunity factors. As survival and subsistence are real considerations for many households that engage in illicit crop cultivation, they are frequently risk-averse and take into account a variety of factors when making decisions on such cultivation. One of those factors is the specific nature of the illicit crops agronomic aspects, durability of the product, price, ease of sale, etc. All major illicit crops are particularly attractive because they produce quick returns from nonperishable products. Illicit crop cultivation can thus provide farmers with the necessary short-term economic means to survive, but it does not allow the area to develop its licit economy and institutional environment. Other factors include geographical and environmental factors, such as climate, the availability of water and arable land, and proximity to market; household-specific socioeconomic factors, such as level of income, existing employment opportunities, access to credit and size of landholding; developmental facilities such as access to roads, the power grid and educational and health services; and sociopolitical and institutional factors, such as security, government control and rule of law. Illicit crop cultivation tends to take place in marginalized, isolated areas characterized by limited government control, unclear land rights, lack of infrastructure, poverty and violence, which are areas where few international development agencies tend to operate. Alternative development is an approach aimed at reducing the vulnerabilities that lead to involvement in illicit crop cultivation and ultimately eliminating such cultivation. Alternative development can break the vicious cycle of rising illicit drug production, weakening rule of law, decreasing growth of the licit economy, decreasing investment in licit sectors, strengthening organized crime and increasing violence by effectively promoting factors fostering a sustainable licit economy. In the long run, this can attract investment and help to develop the necessary infrastructure, thereby changing and sustaining the livelihood of rural communities. Alternative development is not generally an objective in itself but rather a means to an end: it is aimed at contributing to an enabling environment for long-term rural development without illicit crop cultivation. Alternative development acts as a catalyst, boosting development in areas with particular challenges related to the illicit drug economy. The General Assembly at its twentieth special session, held in 1998, defined alternative development as a process to prevent and eliminate illicit crop cultivation through specifically designed rural development measures in the context of sustained national growth and sustainable development efforts in countries taking action against drugs, recognizing the particular sociocultural characteristics of the target communities and groups. 2 This defini- Impact of illicit drug production and of alternative development interventions Weakening of the rule of law Rising illicit drug production Falling poverty and strengthening of the rule of law Falling illicit drug production Reduction in overall growth of the licit economy Vicious circle Strengthening of organized crime and increasing violence Alternative development Increase in overall growth of the licit economy Virtuous circle Weakening of organized crime and falling violence Reduction of investment into licit sectors Increase in investment into licit sectors 2 Action Plan on International Cooperation on the Eradication of Illicit Drug Crops and on Alternative Development (General Assembly resolution S-2/4 E). 215 WORLD DRUG REPORT

20 xviii Member States implementing domestic alternative development projects (as reported to the United Nations Office on Drugs and Crime), Alternative development involvement, Coca Opium Cannabis Plans to introduce alternative development 1, 2, km Sources: UNODC annual report questionnaire and UNODC alternative development projects. Note: Only countries providing sufficient information on the implementation of alternative development projects are included. The boundaries shown on this map do not imply official endorsement or acceptance by the United Nations. Dashed lines represent undetermined boundaries. The dotted line represents approximately the Line of Control in Jammu and Kashmir agreed upon by India and Pakistan. The final status of Jammu and Kashmir has not yet been agreed upon by the parties. The final boundary between the Sudan and South Sudan has not yet been determined. tion is used at the international level. Different definitions reflecting new strategies and approaches of alternative development have been developed by a wide variety of implementing countries, donors and practitioners. National strategies or plans employ a balanced approach, complementing alternative development not only with other supply reduction strategies (particularly law enforcement and interdiction), but also with demand reduction strategies (prevention, treatment and rehabilitation). Another commonly integrated strategy sometimes appearing as a cross-cutting theme or a separate policy is the promotion of good governance or the strengthening of state institutions or the rule of law. Where is alternative development implemented? The bulk of alternative development is implemented in all the main coca- and opium-producing countries, as well as in some cannabis-producing countries and some minor opium-producing countries, which are located in South America, Central America, the Caribbean, Asia and Africa. A number of countries in Asia, Central America, Africa and Europe have also reported plans to implement alternative development activities (see map above). Elements of alternative development Alternative development is promulgated at the international level, but the evolution of alternative development is driven at the country or even the local level. As the factors that push farmers towards illicit crop cultivation can differ greatly from one country or area to another, the strategic elements of alternative development must be tailored to the particular circumstances on the ground at the local level. No two alternative development projects or interventions are exactly alike, even if they are in the same area, but there are commonalities. These general strategic elements are often similar and there are commonalities in the overall framework and approach, but the importance of their roles may vary from project to project and some may not feature at all. Success is very situation-specific and there is no manual or blueprint for alternative development. With the adoption of the United Nations Guiding Principles on Alternative Development, 3 there is now a set of general guidelines outlining good practices in planning and implementing alternative development. The major components that feature, to a greater or lesser extent, in most alternative development projects are as follows: Income-generating alternatives are at the core of alternative development, as economic necessity tends to play an important role in a farmer s decision on whether to engage in illicit crop cultivation. Incomegenerating alternatives need to be viable and sustainable in order to decrease dependence on illicit crop cultivation. 3 General Assembly resolution 68/196, annex.

215 Research UNITED NATIONS OFFICE ON DRUGS AND CRIME Vienna World Drug Report 215 UNITED NATIONS New York, 215 United Nations, May 215. All rights reserved worldwide. ISBN: 978-92-1-148282-9 eisbn: 978-92-1-573-9

References to Chile Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS A. EXTENT OF ILLICIT DRUG USE AND HEALTH CONSEQUENCES El panorama mundial Cocaína In 2010, the regions with a high

WORLD DRUG REPORT 212 UNITED NATIONS OFFICE ON DRUGS AND CRIME Vienna World Drug Report 212 UNITED NATIONS New York, 212 United Nations, June 212. All rights reserved worldwide. ISBN: 978-92-1-148267-6

216 Research WORLD DRUG REPORT UNITED NATIONS OFFICE ON DRUGS AND CRIME Vienna World Drug Report 216 UNITED NATIONS New York, 216 United Nations, May 216. All rights reserved worldwide. ISBN: 978-92-1-148286-7

UNODC-WHO Joint Programme on drug dependence treatment and care The vision Effective and humane treatment for all people with drug use disorders. Nothing less than would be expected for any other disease.

26 WORLD DRUG REPORT Volume 1: Analysis Acknowledgements This report was produced in the Research and Analysis Section of UNODC, under the supervision of Sandeep Chawla and Thibault le Pichon and benefited

EUROPEAN UNION COMMON POSITION ON UNGASS 2016 UNGASS 2016 is a key opportunity for the international community to take stock of the achievements of the international drug control system to date, to elaborate

Annual report 2009: the state of the drugs problem in Europe International Conference: New trends in drug use: facts and solutions, Parliament of the Republic of Vilnius - 5 November 2009 Dagmar Hedrich

UNODC World Drug Report 2016: Launch in Geneva on 23 June 2016 Briefing to the Member States and Civil Society Organizations Remarks by Aldo Lale-Demoz, Deputy Executive Director, UNODC UNODC is honoured

1 METHODOLOGY Considerable efforts have been made over the years to improve the estimates presented in the World Drug Report, which rely, to a large extent, on information submitted by Member States through

3. EAST AND SOUTH-EAST ASIA, OCEANIA AND THE PACIFIC Regional Overview Methamphetamine continues to dominate the ATS market in East and South-East Asia, Oceania and the Pacific. ATS seizures in the region

MUNICATION FROM THE MISSION to the European Parliament and the Council on a EU Drugs Action Plan (2005-2008) Introduction The drugs phenomenon is one of the major concerns of the citizens of Europe and

Produced for the OFFICE OF NATIONAL DRUG CONTROL POLICY Cocaine Smuggling in 2010 Cocaine Flow toward the United States The amount of cocaine departing South America decreased in 2010 for a third straight

The 2012 National Drug Control Strategy: Building on a Record of Reform Taking Action Looking to the Future Moving forward, we will work throughout 2012 to build on a record of progress and reform, with

UNODC United Nations Office on Drugs and Crime 6 December 2013 Original: English The Executive Director Contribution of the Executive Director of the United Nations Office on Drugs and Crime to the high-level

28 WORLD DRUG REPORT Acknowledgements This Report was produced in the Policy Analysis and Research Branch under the supervision of Sandeep Chawla, by the Statistics and Survey Section (headed by Angela

II. NET INTERNATIONAL MIGRATION A. GLOBAL TRENDS During the period 195-21, the developed regions experienced population gains from positive net international migration while the developing regions were

2007 WORLD DRUG REPORT Acknowledgements This report was produced in the Research and Analysis Section of UNODC, under the supervision of Sandeep Chawla and Thibault le Pichon and benefited from the work

Executive Summary For the 2014 analysis report, seizure data from 40 countries was taken into account. Seizures were reported by both police and customs agencies working at international airports. These

Establishing an effective international measure to combat the trafficking of drugs Introduction Vanessa Lim Drug trafficking, otherwise known as the illegal trading and handling of drugs, has been a prevalent

1. TRENDS IN INTERNATIONAL MIGRATION This chapter provides a brief overview of global and regional patterns and trends in international migration since 199. It also describes selected characteristics of

paste in Argentina, Bolivia (Plurinational State of), Chile, Colombia, Ecuador, Peru and Uruguay were found to be 1 per cent or higher. There appears to be a variety of local forms of cocaine base paste,

European Monitoring Centre for Drugs and Drug Addiction UPDATED 28. 5. 2013 PERSPECTIVES ON DRUGS Trends in heroin use in Europe: what do treatment demand data tell us? The current number of problem opioid

PARIS PACT INITIATIVE A partnership to counter trafficwww.paris-pact.net in and consumption of Afghan opiates AN INTERNATIONAL PARTNERSHIP TO COUNTER AFGHAN OPIATES TRAFFICKING AND CONSUMPTION AN INTERNATIONAL

1. Youth Drug Use More than 4% of Maryland high school seniors used an illicit drug in the past year. Any Illicit Drug Alcohol Marijuana Ecstasy Cocaine Percentage of Maryland and U.S. high school seniors

Chapter I. Economic consequences of drug abuse 1. Drug abuse inflicts immeasurable harm on public health and safety around the world each year, and threatens the peaceful development and smooth functioning

2. The opium/heroin market 2.1 Introduction UNODC estimates that there were between 12 and 21 million opiate users worldwide in 29. Heroin remains the most commonly used opiate, consumed by a vast majority

MORTALITY AMONGST ILLICIT DRUG USERS Over the past 40 years the rate of illicit drug use worldwide has risen dramatically, and with it the number of deaths reported among drug-using populations. What are

UNITED NATIONS PRESS RELEASE EMBARGOED UNTIL 3 MAY 2011, 11:00 A.M., NEW YORK TIME World Population to reach 10 billion by if Fertility in all Countries Converges to Replacement Level UNITED NATIONS, 3

THIRD MEETING OF THE INTERGOVERNMENTAL OEA/Ser.L./XIV.4.3 WORKING GROUP ON THE MULTILATERAL CICAD/MEM/doc.14/98 rev. 1 EVALUATION MECHANISM (MEM) 4 December 1998 October 26-28, 1998 Original: Spanish Tegucigalpa,

Number 6 ECONOMIC AND SOCIAL CONSEQUENCES OF DRUG ABUSE AND ILLICIT TRAFFICKING NOTE References to dollars ($) are to United States dollars, unless otherwise stated. This publication has not been formally

9 November 2006 Original: English* Sixteenth Meeting of Heads of National Drug Law Enforcement Agencies, Latin America and the Caribbean Buenos Aires, 23-27 October 2006 Contents Report of the Sixteenth

Dave Burrows Director Effects of drug policy on HIV transmission What is the Comprehensive Package of Services for People Who Inject Drugs (PWID) What is an enabling environment for addressing HIV among

EUROPEAN COMMISSION Brussels, 25.10.2011 COM(2011) 689 final COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL Towards a stronger European response to drugs 1. A STRONGER EUROPEAN

Notes for an Address by Hilary Geller during the General Debate on the Special Session of the UN General Assembly on the World Drug Problem at the 59 th Session of the United Nations Commission on Narcotic

INTERNATIONAL NARCOTICS CONTROL BOARD Report 2013 UNITED NATIONS EMBARGO Observe release date: Not to be published or broadcast before Tuesday, 4 March 2014, at 1200 hours (CET) CAUTION Reports published

Protecting and improving the nation s health Drug treatment in England November 214 About Public Health England Public Health England exists to protect and improve the nation s health and wellbeing, and

CND 57th session POLITICAL Declaration and Plan of ACTION on International COOPERATION TOWARDS an Integrated and Balanced STRATEGY TO Counter the World Drug Problem programme Commission on Narcotic Drugs

The use of illegal drugs in England is declining; people who need help to overcome drug dependency are getting it quicker; and more are completing their treatment and recovering drug treatment in ENGlaND:

Drug Abuse Patterns and Trends in the San Francisco Bay Area Update: June 24 Alice A. Gleghorn, Ph.D. ABSTRACT In San Francisco, increases in heroin consequence indicators (treatment admissions and Drug

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

1. TRANSNATIONAL DRUG MARKET ANALYSIS 1.1 Introduction Since the 196s, and in a context of rapid and deep socioeconomic changes throughout the world, the international drug control system has succeeded

2013 to 2002 States: United the in Use Heroin in Trends National Survey on Drug Use and Health Short Report April 23, 2015 TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013 AUTHORS Rachel N. Lipari,

Acknowledgements The Improving ATS Data and Information Systems project is managed by the United Nations Office on Drugs and Crime Regional Centre for East Asia and the Pacific. It is the primary mechanism

Drug Use and Abuse in San Diego County, California: 213 Karla D. Wagner, Ph.D. 1 ABSTRACT The most significant change observed in drug use/abuse indicators in San Diego County in 213 was an increase in

CHAPTER 6 LAW ENFORCEMENT AND DRUG-RELATED CRIME MARY O BRIEN 6.1 Introduction Drug-related data from law enforcement agencies are collected and published each year by An Garda Síochána. These data reflect

REMARKS BY R. GIL KERLIKOWSKE DIRECTOR OFFICE OF NATIONAL DRUG CONTROL POLICY EXECUTIVE OFFICE OF THE PRESIDENT before the CENTER FOR STRATEGIC AND INTERNATIONAL STUDIES DRUG POLICY IN THE AMERICAS JULY

United Nations S/2008/434 Security Council Distr.: General 3 July 2008 Original: English Special report of the Secretary-General pursuant to Security Council resolution 1806 (2008) on the United Nations

CHAPTER II ALTERNATIVE DEVELOPMENT A. INTRODUCTION Origin of alternative development As one of the three pillars of the international community s balanced approach towards drug control, alternative development,

Karla Ramirez, LCSW Director, Outpatient Services Laurel Ridge Treatment Center 1 in 4 Americans will have an alcohol or drug problems at some point in their lives. The number of alcohol abusers and addicts

EXECUTIVE SUMMARY HIV/AIDS is the deadliest epidemic of our time. Over 22 million people have already lost their lives, and more than 42 million are currently living with HIV/AIDS. Even if a vaccine for

Differences in patterns of drug use between women and men Differences in patterns of drug use between women and men Key findings Introduction Cannabis Ecstasy Tranquillisers and sedatives Alcohol and drug

INTERNATIONAL NARCOTICS CONTROL BOARD Precursors and chemicals frequently used in the illicit manufacture of narcotic drugs and psychotropic substances 2014 UNITED NATIONS EMBARGO Observe release date:

ECONOMIC AND SOCIAL COUNCIL Substantive session of 2013 - General Segment - Geneva, 18-25 July 2013 Monday, 22 July 2013, 10 a.m.- 12 noon Panel discussion: Focus on the Vienna based Commissions and the

Address by Gary Lewis, Representative, United Nations Office on Drugs and Crime, Regional Centre for East Asia and the Pacific at the workshop on Exploring ATS Treatment Availability and Structured Guidelines